Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT 5) for Pediatric Irritable Bowel Syndrome and Pediatric Functional Constipation

Gastroenterology Regulatory Endpoints and the Advancement of Therapeutics (GREAT 5) for Pediatric Irritable Bowel Syndrome and Pediatric Functional Constipation

The American College of Gastroenterology (ACG), American Gastroenterological Association (AGA), North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and FDA will be cosponsoring a public workshop in Silver Spring, Maryland on March 28, 2018 from 8:00 a.m. to 5:00 p.m.

The focus of this public workshop is Pediatric Irritable Bowel Syndrome and Pediatric Functional Constipation.  The co-sponsored workshop will facilitate the ongoing dialogue among relevant parties on issues related to Pediatric Irritable Bowel Syndrome and Pediatric Functional Constipation. 

At this time, live streaming of the presentations is planned and transcripts of the presentations will be available within 30 days following the workshop. Live streaming may be accessed at https://collaboration.fda.gov/greatv/

On-site registration will not be available. Participants (both in-person attendees and remote participants) should register here.

For questions related to registration, please email GREAT@fda.hhs.gov

Please see the link below for information on the venue, local hotels and FDA campus security procedures:

https://www.fda.gov/aboutfda/workingatfda/buildingsandfacilities/whiteoakcampusinformation/ucm241740.htm

Click Here for the agenda